Drug distributor McKesson Corp. says it expects to shoulder more than $100 million in opioid-related legal expenses this year. Both McKesson and AmerisourceBergen downplayed their roles in the opioid epidemic in their respective earnings calls.
McKesson expects opioid-related legal costs to exceed $100 million this year
